Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
Cash Flows From Operating Activities | |||||
Net Income | 4,800,000 | 4,017,000 | 2,694,000 | 1,314,000 | 4,167,000 |
Depreciation Amortization | 1,515,000 | 1,239,000 | 832,000 | 431,000 | 1,444,000 |
Income taxes - deferred | -128,000 | N/A | N/A | N/A | -26,000 |
Accounts receivable | -427,000 | -224,000 | -309,000 | -200,000 | -607,000 |
Other Working Capital | 328,000 | 194,000 | -227,000 | 31,000 | 62,000 |
Other Operating Activity | 475,000 | 224,000 | 309,000 | 200,000 | 637,000 |
Operating Cash Flow | $6,563,000 | $5,450,000 | $3,299,000 | $1,776,000 | $5,677,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,485,000 | -1,040,000 | -659,000 | -292,000 | -1,728,000 |
Net Acquisitions | -68,000 | -7,000 | -7,000 | -7,000 | -271,000 |
Purchase Of Investment | -5,676,000 | -3,805,000 | -2,187,000 | -817,000 | -3,832,000 |
Sale Of Investment | 4,827,000 | 3,405,000 | 2,189,000 | 765,000 | 3,057,000 |
Other Investing Activity | 34,000 | -104,000 | -92,000 | 16,000 | -168,000 |
Investing Cash Flow | $-2,368,000 | $-1,551,000 | $-756,000 | $-335,000 | $-2,942,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 814,000 | 491,000 | 162,000 | 280,000 | 3,208,000 |
Debt Issued | 591,000 | 593,000 | 6,000 | 8,000 | 793,000 |
Debt Repayment | -35,000 | -35,000 | -22,000 | -15,000 | -187,000 |
Common Stock Issued | 387,000 | 267,000 | 226,000 | 60,000 | 221,000 |
Common Stock Repurchased | -973,000 | -621,000 | -369,000 | -208,000 | -840,000 |
Dividend Paid | -1,724,000 | -1,279,000 | -826,000 | -381,000 | -1,479,000 |
Other Financing Activity | -2,160,000 | -1,359,000 | -1,086,000 | -865,000 | -4,010,000 |
Financing Cash Flow | $-3,100,000 | $-1,943,000 | $-1,909,000 | $-1,121,000 | $-2,294,000 |
Exchange Rate Effect | -47,000 | -73,000 | -25,000 | -20,000 | -72,000 |
Beginning Cash Position | 2,363,000 | 2,512,000 | 2,512,000 | 2,363,000 | 1,994,000 |
End Cash Position | 3,411,000 | 4,395,000 | 3,121,000 | 2,663,000 | 2,363,000 |
Net Cash Flow | $1,048,000 | $1,883,000 | $609,000 | $300,000 | $369,000 |
Free Cash Flow | |||||
Operating Cash Flow | 6,563,000 | 5,450,000 | 3,299,000 | 1,776,000 | 5,677,000 |
Capital Expenditure | -1,689,000 | -1,070,000 | -690,000 | -310,000 | -1,822,000 |
Free Cash Flow | 4,874,000 | 4,380,000 | 2,609,000 | 1,466,000 | 3,855,000 |